Developing A System To Prevent Misidentification Of TB Patient Samples
Accurate tuberculosis diagnosis depends on more than a sensitive test or a well-maintained instrument. Every result begins with the correct patient, the correct specimen, and an unbroken connection between the sample and the report. If that identity chain fails, a technically valid test can still lead to the wrong clinical decision.
Mislabelled, swapped, duplicated, or inadequately documented specimens can cause delayed treatment, inappropriate therapy, missed drug resistance, and avoidable exposure to infection. A reliable laboratory therefore needs a deliberate specimen identification system that covers collection, transport, reception, testing, storage, reporting, and disposal.
The most effective approach combines clear responsibilities, standardized identifiers, physical checks, readable records, and regular review of errors and near misses. The four-phase GLI Quality Tool roadmap can help laboratories introduce these controls gradually while considering available staff, equipment, workload, and infrastructure.
Map The Complete Specimen Identity Chain
A laboratory should first document how a TB patient sample moves from the point of care to the final result. This process map should include sputum collection, referral from another facility, packaging, transport, reception, accessioning, testing, storage, referral to another laboratory, and result dispatch. Each handoff is a possible point at which a specimen can be separated from its patient information.
The map should identify who performs each activity, which records are created, and what happens when information is missing or inconsistent. A sample should never proceed simply because the container arrived. Staff need a defined process for resolving discrepancies, including who may authorize acceptance, rejection, recollection, or corrective documentation.
The system should also distinguish patient identifiers from specimen identifiers. A patient may provide multiple samples on different dates, while one specimen may generate several tests. Assigning a unique accession or laboratory number to each sample reduces confusion and makes it possible to trace every aliquot, test result, and stored remainder back to the original request.
Standardize Identifiers And Labelling
A written specimen labelling procedure should state the minimum information required on the container and accompanying request form. Depending on national policy and local workflow, this may include the patient’s full name or approved coded identifier, date of birth or age, patient number, specimen type, collection date, collection time, and requesting facility. The same identifiers should appear consistently across paper and electronic records.
Labels must be placed on the specimen container rather than only on a transport bag. They should remain legible under condensation, refrigeration, disinfectant exposure, and routine handling. Preprinted labels, durable markers, barcode systems, or coded labels may be used according to the laboratory’s resources, but every method needs a backup procedure for damaged, incomplete, or unreadable labels.
At collection, the person obtaining the specimen should identify the patient using the locally approved process and compare the information with the request form before accepting the sample. For patients who cannot provide information, staff should follow an authorized alternative identification procedure rather than inventing temporary identifiers that may later be reused.
Build Verification Checks Into Every Handoff
A strong process uses at least two identifiers when a specimen is collected, received, tested, or reported. Staff should compare the container, request form, transport documentation, and laboratory information system where available. The check should be active and visible, not an assumption based on a familiar patient name or a sealed package.
Reception staff should inspect the sample before accessioning it. Important checks include the condition of the container, label completeness, matching identifiers, specimen type, collection date, volume or quality requirements, and evidence of leakage or tampering. A discrepancy should trigger a documented decision based on risk. In some cases, recollection is safest; in others, testing may be permitted with a qualified comment and notification to the requester.
| Process point | Essential control | Evidence to retain | Response to a discrepancy |
|---|---|---|---|
| Collection | Verify two patient identifiers before labelling | Request form and collector record | Stop and clarify before the sample leaves |
| Transport | Match containers to the manifest and secure the package | Dispatch and receipt log | Quarantine unmatched or damaged items |
| Reception | Compare label, form, and accession record | Accession entry and rejection record | Hold, investigate, or reject according to policy |
| Testing | Confirm identity before aliquoting and loading | Worksheet, barcode scan, or run record | Stop the run if identity is uncertain |
| Reporting | Match result to the authorized patient record | Reviewed report and transmission log | Correct, notify, and assess affected results |
| Storage and disposal | Keep retained specimens traceable | Inventory and disposal record | Investigate missing or unexplained specimens |
Two-person verification can be valuable for high-risk steps, such as assigning a new accession number, preparing aliquots, resolving a mismatch, or releasing a corrected report. It should be used where it adds protection without creating a superficial signature exercise. Both staff members must independently compare the identifiers and record the check.
Control Paper And Electronic Records
Specimen identity errors often arise when information is copied repeatedly between request forms, registers, worksheets, spreadsheets, and laboratory information systems. Each transcription creates an opportunity for a wrong digit, reversed name, duplicate accession number, or mismatched test request. The laboratory should minimize unnecessary copying and define which record is authoritative at each stage.
Where electronic systems are available, barcode scanning and restricted user permissions can reduce manual entry. However, electronic tools do not replace verification. A barcode linked to the wrong patient at collection will reproduce the original error efficiently. Staff should confirm that the displayed patient details match the physical specimen before scanning, aliquoting, or testing.
Paper systems require equally careful controls. Accession books should use sequential numbers without unexplained gaps, corrections should remain readable and be signed or initialled, and blank spaces should not permit later additions. Forms should be stored securely because TB records contain sensitive health information. User instructions can support consistent use of the GLI Quality Tool materials as the laboratory adapts documentation and workflow controls to its setting.
Manage Mismatches, Recollections, And Corrected Reports
A specimen with conflicting identifiers should be placed in a clearly marked hold area or assigned an electronic status that prevents accidental testing. Staff should never silently alter a label or overwrite a record to make the information agree. The original discrepancy, people contacted, decision taken, and reason for that decision should be documented.
The laboratory needs a written policy for several common situations: an unlabeled specimen, a partially labelled container, two samples with identical identifiers, a form that does not match the container, a sample received without a request form, and a result already issued for a subsequently identified mismatch. The policy should define who can authorize action and when the clinician or collection site must be contacted.
When a wrong-patient or uncertain-patient result may have been reported, the event should be escalated immediately. The laboratory should identify potentially affected specimens and results, notify responsible clinical personnel, issue a corrected report when required, and support recollection. The investigation should focus on system weaknesses rather than blame, while still addressing unsafe conduct and training needs.
Train Staff And Measure Reliability
Training should be practical and role-specific. Collectors need to practise patient verification and bedside labelling; couriers need to check manifests and package integrity; reception staff need to assess acceptance criteria; testing personnel need to verify identity before processing; and supervisors need to review incidents and authorize corrective action.
Competency assessment should include direct observation, record review, and simulated discrepancy scenarios. New staff should complete training before working independently, while experienced staff should be reassessed after procedure changes, technology upgrades, or significant incidents. Short refresher sessions can address recurring problems more effectively than occasional general lectures.
Useful indicators include the percentage of specimens rejected for identification problems, mismatches detected before testing, mismatches detected after testing, recollection rates, missing accession numbers, and the time taken to resolve discrepancies. Results should be reviewed by collection site, staff role, shift, specimen type, and transport route when appropriate. A rise in reported near misses may initially reflect better detection rather than poorer performance.
Turn Findings Into Continual Improvement
A quality management system becomes reliable when data lead to action. Monthly or quarterly review can reveal patterns such as errors concentrated at one clinic, problems during night shifts, illegible labels from a particular printer, or recurrent confusion between serial samples. Corrective actions should address the cause, assign an owner, include a deadline, and be checked for effectiveness.
Practical improvements may include redesigned forms, clearer rejection criteria, dedicated specimen reception space, improved lighting, barcode adoption, collection-site coaching, or changes to transport manifests. Laboratories should test changes on a manageable scale and compare performance before and after implementation. Procedures should be revised when evidence shows that the current process is difficult to follow or fails to control risk.
Staff should be encouraged to report near misses without fear of automatic punishment. A near miss is valuable evidence that a barrier worked or that a hazard remains. When findings are shared during routine quality meetings, personnel can see how careful identification protects patients, preserves trust in results, and prevents wasted testing capacity.
Key actions for a dependable identification system include:
- Define two approved patient identifiers and one unique specimen accession number.
- Require matching checks at collection, reception, testing, reporting, and storage.
- Quarantine and document every specimen with uncertain or conflicting identity.
- Train each role using realistic examples and assess competency periodically.
- Track errors and near misses, then verify that corrective actions actually reduce risk.
A laboratory can begin with a process map, a simple acceptance checklist, and a clearly defined discrepancy log, then strengthen controls as resources permit. Review the relevant GLI Quality Tool materials, involve collection and clinical partners, and record local lessons through the feedback form so that specimen identification becomes a routinely verified part of safe TB diagnosis.